Minocycline HCl
Drug1mg microspheres for professional subgingival administration into periodontal pockets two times throughout the duration of the trial
Other names: antibiotic
NCT Number: NCT00662532
This study is for people at least 21 years old who have signs of problems, like swollen gums and shrinking bones, by dental implants.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 3
JJCPPW Investigational Site, Aurora, Colorado, United States
At Visit 1, the dentist will:
At Visit 2 (Baseline), the dentist will:
At Visit 4 (about 3 months later), the dentist will:
At Visit 5 (about 6 months later), the dentist will:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1mg microspheres for professional subgingival administration into periodontal pockets two times throughout the duration of the trial
Other names: antibiotic
Time frame: Baseline to Day 180
Mean reduction of probing depth (PD) of qualified implant sites is derived by calculating the change of PD per qualified implant site (PD at baseline minus PD at post-baseline), and then averaging the site-specific PD changes per subject
Time frame: Baseline to Day 90
Mean reduction of probing depth (PD) of qualified implant sites is derived by calculating the change of PD per qualified implant site (PD at baseline minus PD at post-baseline), and then averaging the site-specific PD changes per subject
Time frame: at Day 90 and Day 180
Bleeding on Probing (BOP) percentage is calculated as the number of implant sites with bleeding divided by the number of implant sites per subject times 100% at each visit; reduction of BOP percentage is the BOP percentage at baseline minus the BOP percentage post-baseline
OraPharma
Industry
Multi-Center Phase 3 Trial of Minocycline HCl 1mg Microspheres for the Use in Subjects With Peri-Implantitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02671812
Behavior, Digestive System Diseases
View Trial DetailsNCT07055256
Mouth Diseases, Peri-Implantitis
Santiago, Chile
View Trial DetailsNCT05061511
Inflammation, Mouth Diseases
Parma, Italy
View Trial DetailsNCT06852599
Mouth Diseases, Peri-Implant Health
Heidelberg, Baden-Wurttemberg, Germany
View Trial Details